Mirae Asset Global Investments Co., Ltd. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Mirae Asset Global Investments Co., Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$144.95 - $152.29 $1.24 Million - $1.3 Million	8,560 Added 48.04%	26,380 $3.99 Million
Q2 2022 Jul 26, 2022	BUY	$83.14 - $145.99 $1.48 Million - $2.6 Million	17,820 New	17,820 $2.6 Million
Q2 2021 Aug 11, 2021	SELL	$65.78 - $105.02 $944,863 - $1.51 Million	-14,364 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$64.07 - $91.75 $51,448 - $73,675	-803 Reduced 5.29%	14,364 $982,000
Q4 2020 Feb 10, 2021	SELL	$65.07 - $98.24 $707,506 - $1.07 Million	-10,873 Reduced 41.75%	15,167 $1.3 Million
Q3 2020 Nov 12, 2020	BUY	$59.04 - $77.95 $512,467 - $676,606	8,680 Added 50.0%	26,040 $1.65 Million
Q2 2020 Aug 11, 2020	BUY	$29.01 - $74.23 $503,613 - $1.29 Million	17,360 New	17,360 $1.27 Million
Q4 2018 Feb 11, 2019	SELL	$29.75 - $42.9 $892,500 - $1.29 Million	-30,000 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$32.79 - $43.0 $983,700 - $1.29 Million	30,000 New	30,000 $1.13 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.